BridgeBio lands $1 billion, mostly from S.F.’s Sixth Street, with three late-stage drugs in hand

July 1, 2026 San Francisco Biotechnology Network News News, Syndication Comments Off on BridgeBio lands $1 billion, mostly from S.F.’s Sixth Street, with three late-stage drugs in hand

Some of the money is coming from a San Francisco-based investment firm.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks